Archives
-
IPR-803: A Urokinase Receptor Inhibitor Workflow
2026-09-28
Use IPR-803 to probe uPAR–uPA-dependent invasion without assuming that every change in motility reflects target engagement. This workflow connects biochemical competition assays with breast and pancreatic cancer models, while distinguishing free-compound experiments from formulation-dependent in vivo evidence.
-
Acifran for HCAR2/HCAR3 Lipid Signaling Research
2026-09-27
Use Acifran to connect receptor activation with lipid-signaling readouts and compare HCAR2/GPR109A with HCAR3/GPR109B in controlled cell assays. A recent cryo-EM study provides a structural rationale for building those comparisons into assay design, while practical preparation and troubleshooting guidance helps improve reproducibility.
-
CNQX and the Logic of Glutamate Circuit Tests
2026-09-26
CNQX is more than an AMPA/kainate blocker: used with site-specific controls, it can help distinguish where glutamate-receptor signaling contributes to a circuit response. This article examines what a negative CNQX result can—and cannot—tell researchers about brainstem-to-hypothalamic cardiovascular pathways.
-
Room-Temperature Stability of Lyophilized mRNA-LNPs
2026-09-25
Wang et al. identified a lyophilization condition—5 mM Tris at pH 8 with 10% sucrose—that preserved key mRNA-LNP attributes and supported consistent in vivo monoclonal antibody expression after one month of room-temperature storage. The study connects formulation properties with biological performance and provides a basis for further stability testing, while leaving longer-term storage and broader formulation transferability to be established.
-
Niclosamide: Translating STAT3 Signals into Evidence
2026-09-25
A translational framework for using Niclosamide to connect STAT3 pathway modulation with cell-cycle and apoptosis readouts—while keeping model-specific evidence, formulation constraints, and cross-domain claims in perspective.
-
Bufuralol Beyond the Receptor: A Translational Roadmap
2026-09-24
Bufuralol hydrochloride offers a useful way to interrogate β-adrenergic pharmacology precisely because its antagonist activity is accompanied by partial intrinsic sympathomimetic behavior. This article outlines how to validate those context-dependent effects and where human iPSC-derived intestinal organoids could—and could not yet—add pharmacokinetic context to cardiovascular research.
-
LY2109761 for TGF-β–Driven Glioma Invasion
2026-09-24
Use LY2109761 to test whether TGF-β receptor signaling connects OLIG2 state to glioma invasion, with phospho-Smad and migration readouts providing complementary evidence. The workflow also highlights how to adapt dual-receptor inhibition for pancreatic cancer, glioblastoma radiosensitivity, and fibrosis research without treating preclinical findings as clinical guidance.
-
SM-102 for Localized mRNA Delivery Workflows
2026-09-23
SM-102 is an ionizable lipid building block for researchers optimizing lipid nanoparticles that carry mRNA into cells. A bladder-cancer study illustrates how localized delivery can extend mRNA research beyond vaccines, while the workflow below separates reported findings from practical starting conditions that still require optimization.
-
Directed Differentiation of hiPSCs into Corneal Endothelium
2026-09-23
Diao and colleagues developed a two-stage, chemically defined, serum-free strategy for converting human induced pluripotent stem cells into neural crest cells and then human corneal endothelial cell-like cells. Coordinated TGF-β and Wnt pathway modulation, followed by marker-based molecular and morphological validation, provides a practical framework for studying cell-based approaches to corneal endothelial repair.
-
Docosahexaenoic Acid (DHA): Research Guide
2026-09-22
Docosahexaenoic Acid (DHA) is a membrane-enriched omega-3 fatty acid studied in neural, retinal, inflammatory, and nutritional research. Its strongest mechanistic rationale involves phospholipid organization and conversion into specialized pro-resolving mediators, while cell-based neuroprotection findings should not be treated as clinical efficacy.
-
Ionophore Toxicity: Molecular and Clinical Insights
2026-09-22
This review integrates clinical observations with molecular explanations for polyether ionophore toxicity in animals, emphasizing dose, species, age, ion dysregulation, and impaired oxidative phosphorylation. Its main practical contribution is a framework for interpreting muscle injury and drug interactions while assessing how ionophore biology may inform carefully controlled antibacterial and anticancer research.
-
TGF-β, Sca-1, and Mammary Cell Plasticity
2026-09-21
The 2020 Scientific Reports study shows that TGF-β regulates Sca-1 expression while altering lineage commitment and tumor-initiating potential in pre-neoplastic and cancer-associated mammary epithelial cells. Its key contribution is the distinction between endogenous Smad2/3/4-dependent regulation and exogenous TGF-β-driven Sca-1 loss that is independent of Smad2/3, providing a framework for studying epithelial plasticity and stem-like states.
-
Moxidectin for Antifungal Synergy Research
2026-09-21
Moxidectin is a macrocyclic lactone anthelmintic with an emerging laboratory use as a polyene-sensitizing compound in Candida albicans assays. This guide converts the published ergosterol-based finding into practical checkerboard, biofilm, sterol, genetic-validation, and troubleshooting workflows while distinguishing preclinical evidence from established veterinary antiparasitic applications.
-
Levofloxacin: From Resistance Data to Assay Design
2026-09-20
Levofloxacin is a synthetic fluoroquinolone antibiotic that connects DNA replication research with resistance surveillance and bone-cell assays. This article presents an evidence-centered framework for selecting phenotypic, genetic, and cell-based readouts.
-
GSH and GSSG Assay Kit: Redox in Tumors
2026-09-19
A thought-leadership analysis of how glutathione redox measurements can connect tumor hypoxia, immunometabolism, and translational study design, with practical guidance for using the GSH and GSSG Assay Kit in research workflows.